STERIS plc
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B |
| Cost of Revenue | $3.31B | $3.06B | $2.92B | $2.56B | $2.34B | $1.76B | $1.71B | $1.61B |
| Gross Profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B | $1.34B | $1.32B | $1.17B |
| Gross Margin | 44.2% | 44.0% | 43.2% | 43.7% | 44.6% | 43.2% | 43.6% | 42.2% |
| Operating Expenses | ||||||||
| Research & Development | $112.9M | $107.6M | $103.7M | $98.5M | $86.7M | $66.3M | $65.5M | $63.0M |
| SG&A Expense | $1.41B | $1.33B | $1.25B | $1.09B | $1.32B | $731.3M | $716.7M | $669.9M |
| Operating Income | $1.10B | $866.6M | $836.1M | $791.1M | $477.8M | $548.4M | $537.0M | $411.0M |
| Operating Margin | 18.6% | 15.9% | 16.3% | 17.4% | 11.3% | 17.6% | 17.7% | 14.8% |
| Interest Expense | — | — | $144.4M | $108.0M | $89.5M | $37.2M | $40.3M | $45.0M |
| Pretax Income | $1.05B | $796.2M | $702.8M | $680.3M | $366.8M | $517.5M | $498.8M | $369.0M |
| Income Tax Expense | $262.2M | $184.7M | $149.5M | $124.1M | $82.3M | $120.7M | $90.9M | $64.3M |
| Net Income | $782.3M | $614.6M | $378.2M | $107.0M | $243.9M | $397.4M | $407.7M | $303.7M |
| Net Margin | 13.2% | 11.3% | 7.4% | 2.4% | 5.8% | 12.8% | 13.5% | 10.9% |
| EPS (Basic) | $7.97 | $6.24 | $3.83 | $1.07 | $2.50 | $4.66 | $4.81 | $3.59 |
| EPS (Diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 |
| Shares Outstanding (Basic) | 98.2M | 98.6M | 98.8M | 99.7M | 97.5M | 85.2M | 84.8M | 84.6M |
| Shares Outstanding (Diluted) | 98.7M | 99.1M | 99.4M | 100.2M | 98.3M | 85.9M | 85.6M | 85.5M |
| Dividends Per Share | $2.46 | $2.23 | $2.03 | $1.84 | $1.69 | $1.57 | $1.45 | $1.33 |